Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

The (Un)importance of Numbers: A Proposed Change in Approach to Residual Reproductive Risk Assessment

NSGC 2024 43rd Annual Conference

National Society of Genetic Counselors

New Orleans, LA, Sep 17-21, 2024

Poster presentation: The (Un)importance of Numbers: A Proposed Change in Approach to Residual Reproductive Risk Assessment

Authors: Wilkinson J, Niemchak T, Harper C, Subas T

Specialty: Genetics, Women's Health

Related content

On-Demand Webinar
The Link Between Reproductive Abnormalities and Cardiometabolic Conditions
On-Demand Webinar
Demystifying the Diagnosis of Polycystic Ovary Syndrome
Audio Podcast
Insights into successful family planning: A diagnostics perspective
By: Damian “Pat” Alagia, III, MD, MS, MBA, FACS, FACOG
Audio Podcast
A Commitment to Women’s Health
Publication
Multisite Evaluation and Validation of Optical Genome Mapping for Prenatal Genetic Testing
Conference Presentation
The Proportion of Reportable cfDNA Screening Results for Fetal Aneuploidy in Pregnancies Less Than 10 Weeks Gestation

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.